| Upcoming IPOs | IPO Date | size |
|---|
Blackstone Says Deal Cycle Has Hit 'Escape Velocity' As IPO, M&A Activity 'Feels Like 2013' Again
Private equity giant Blackstone Inc. (NYSE: BX) said that the long-awaited recovery in global dealmaking is now firmly underway, with executives pointing to accelerating IPO and M&A activity following a multi-year freeze.During the company's fourth-quarter earnings call on Thursday, Chief Operating Officer Jonathan Gray said, "This is an exciting time for Blackstone, with three powerful dynamics coming together," pointing to the reopening of the deal cycle, rising investment tied to artificial intelligence and growing adoption of private markets across investor channels.
Why a company goes public and how you sh...
Each week we discuss the current happenings of the IPO (Initial Public Offering) market to keep you updated on anything that may be coming u...
Why a company goes public and how you sh...
Each week we discuss the current happenings of the IPO (Initial Public Offering) market to keep you updated on anything that may be coming u...
Dissecting IPO markets for 2016.
Previously we discussed the health of the IPO market as it relates to the number of deals, proceeds, and performance. Today we dig a little...
Dissecting IPO markets for 2016.
Previously we discussed the health of the IPO market as it relates to the number of deals, proceeds, and performance. Today we dig a little...
Who should invest in IPO's?
IPO's, or initial public offerings can be a hot topic issue in the financial advisory / investment services industry. On one hand some of th...
Who should invest in IPO's?
IPO's, or initial public offerings can be a hot topic issue in the financial advisory / investment services industry. On one hand some of th...
IPO Update: BELLUS Health Announces Open...
Recently Priced Today saw the introduction of BELLUS Health (NASDAQ:BLU) that is priced at $7.10 a share with 9,859,155 shares. BELLUS Healt...
IPO Update: BELLUS Health Announces Open...
Recently Priced Today saw the introduction of BELLUS Health (NASDAQ:BLU) that is priced at $7.10 a share with 9,859,155 shares. BELLUS Healt...
How to go IPO (and buy shares of new com...
Brian Herman is Managing Director of Viewtrade Securities. He has worked in the securities and investment banking businesses since the 1990'...
How to go IPO (and buy shares of new com...
Brian Herman is Managing Director of Viewtrade Securities. He has worked in the securities and investment banking businesses since the 1990'...
A good start for 2016 IPO’s
The first IPO's of 2016 hit the market this week and both were biotech company's. Although 81% of all 2015 biotech IPO's trade below opening...
A good start for 2016 IPO’s
The first IPO's of 2016 hit the market this week and both were biotech company's. Although 81% of all 2015 biotech IPO's trade below opening...
